Envision Healthcare Reports 2016 Fourth Quarter and Full Year Financial Results

Go back to Envision Healthcare Reports 2016 Fourth Quarter and Full Year Financial Results

Envision Healthcare (EVHC) PT Lowered to $82 at Jefferies; Reiterates Buy

March 1, 2017 6:59 AM EST

Jefferies lowered its price target on Envision Healthcare (NYSE: EVHC) to $82.00 (from $90.00) while maintaining a Buy rating.

Analyst Brian Tanquilut commented, "Investors have been anticipating a volume-driven FY17 guidance miss for the last few months, as evidenced by the discount in its valuation,... More